Ateronon Heart+
Commercial- Indications
- Cardiovascular health
Company intelligence / Profile preview
The company offers a range of science-backed dietary supplements with proven bioavailability. Its flagship products include LactoLycopene-based Ateronon Heart+ and Turmeric+, both supported by published scientific data and clinical trials. The company continues to expand its portfolio through acquisitions such as Prime Fifty and GP Nutrition. It serves over 100,000 customers with more than £4 million in annual revenue. No pharmaceutical clinical trial results are reported; efficacy claims are based on supplement studies.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FutureYou Cambridge.